Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors.
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors. Cancer Chemother Pharmacol. 2014 Jul; 74(1):195-204.